SEC Comment Letter 0000000000-23-013975 to Better Therapeutics, Inc. (CIK 0001832415)
Better Therapeutics, Inc. (CIK 0001832415)
Date: Dec. 21, 2023 · CIK: 0001832415 · Accession: 0000000000-23-013975
AI Filing Summary & Sentiment
File numbers found in text: 333-276030
Letter
United States securities and exchange commission logo December 21, 2023 Frank Karbe Chief Executive Officer Better Therapeutics, Inc. 548 Market Street, #49404 San Francisco, CA 94104 Re:Better Therapeutics, Inc. Amendment No. 1 to Registration Statement on Form S-1 Filed December 18, 2023 File No. 333-276030 Dear Frank Karbe: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Juan Grana at 202-551-6034 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Sam Zucker, Esq.
Show Raw Text
United States securities and exchange commission logo
December 21, 2023
Frank Karbe
Chief Executive Officer
Better Therapeutics, Inc.
548 Market Street, #49404
San Francisco, CA 94104
Re:Better Therapeutics, Inc.
Amendment No. 1 to Registration Statement on Form S-1
Filed December 18, 2023
File No. 333-276030
Dear Frank Karbe:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Juan Grana at 202-551-6034 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Sam Zucker, Esq.